Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Agents and Actions

• Publication date

  1985-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF01999630PMID 4003192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.

  1984cited by this paper
• Inflammatory characteristics of platelet activating factor (PAF‐acether) in human skin

  1984cited by this paper
• Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys.

  1984cited by this paper
• PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.

  1984cited by this paper
• Inflammatory actions of platelet activating factor (Paf‐acether) in guinea‐pig skin

  1983cited by this paper
• An In Vivo Model for Studying Platelet Aggregation and Disaggregation

  1982cited by this paper
• Nonimmunological production of leukotrienes induced by platelet-activating factor.

  1982cited by this paper
• Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues.

  1982cited by this paper
• Aldosterone metabolism in isolated perfused rat kidney.

  1978cited by this paper
• Endocrine-type antihypertensive function of renomedullary interstitial cells.

  1975cited by this paper

• The pathophysiological effects of Russell's viper (Daboia siamensis) venom and its fractions in the isolated perfused rabbit kidney model: A potential role for platelet activating factor

  2020cites this paper
• Platelet-activating factor receptor affects food intake and body weight

  2015cites this paper
• Platelet-activating factor receptor antagonism improves cerebral recovery after circulatory arrest.

  1999cites this paper
• Sepsis in the critically ill patient.

  1995cites this paper
• Lyso-PAF:acetyl-CoA acetyltransferase and CDP-choline cholinephosphotransferase activities in the rabbit endometrium.

  1995cites this paper
• Role of R‐type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet‐activating factor

  1994cites this paper
• Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.

  1994cites this paper
• Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure.

  1994cites this paper
• Meningocortical lesion increases expression of the cholecystokinin gene in rat cerebral cortex: evidence for the involvement of platelet-activating factor (PAF).

  1993cites this paper
• Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock.

  1993cites this paper
• Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice.

  1991cites this paper
• The effects of R-75,317 on antiglomerular basement membrane glomerulonephritis in rats

  1991cites this paper
• The role of platelet-activating factor (PAF) in experimental glomerular injury

  1991cites this paper
• Increased urinary excretion of platelet activating factor in mice with lupus nephritis.

  1991cites this paper
• Platelet-activating factor antagonist, BN-52021 protects against cis-diamminedichloroplatinum nephrotoxicity in the rat.

  1990cites this paper
• [Platelet activating factor--a biologically active phospholipid].

  1990cites this paper
• Interactions of platelet activating factor and prostaglandins in the glomerulus and in mesangial cells.

  1989cites this paper
• Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies.

  1989cites this paper
• Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.

  1989cites this paper
• Involvement of platelet-activating factor in renal processes.

  1989cites this paper
• Paf-acether (platelet-activating factor) and interleukin-1-like cytokine production by lipopolysaccharide-stimulated glomeruli.

  1988cites this paper
• Cyclosporine-induced nephrotoxicity: preventive effect of a PAF-acether antagonist, BN 52063.

  1988cites this paper
• Protection of platelet-activating factor-induced acute renal failure by BN 52021.

  1988cites this paper
• Are blood platelets involved in the pathogenesis of ischemic brain edema in gerbils?

  1988cites this paper
• Metabolism of 1-alkyl-2-acyl-GPC in human platelets in response to stimulation by thrombin.

  1987cites this paper
• Renal anaphylaxis. I. Antigen-initiated responses from isolated perfused rat kidney.

  1987cites this paper
• Interaction between prostaglandin E2 and leukotriene D4 on the excretion of electrolytes by the dog kidney in vivo.

  1987cites this paper
• Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis.

  1987cites this paper
• Platelet-activating factor antagonists.

  1987cites this paper